Physician

Brian M. Renard

According to 2025 Medicare claims, Brian Renard (NPI: 1609160415) practices interventional cardiology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (NPI: 1578072906; TIN: 82-2784244) and primary practice location at 48073-6712.

Renard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 923 traditional Medicare patients, billed 2,284 HCPCS/CPT codes, and received $192,871 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,246 prescription claims across 712 beneficiaries totaling $1,233,806 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 34 records totaling $12,580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $87,899 to $192,871. Similarly, Part D prescription costs have risen steadily, from $649 to $1,233,806. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$118K$236K2019 Medicare payment: $87,899 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $76,580 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $175,930 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $235,997 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $216,138 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $192,871 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019518983$87,899
2020450929$76,580
20219002,112$175,930
20221,0992,832$235,997
20239872,602$216,138
20249232,284$192,871

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$617K$1.2M2016 Drug cost: $649 (USD; Tot_Drug_Cst)2017 Drug cost: $5,756 (USD; Tot_Drug_Cst)2018 Drug cost: $856 (USD; Tot_Drug_Cst)2019 Drug cost: $7,444 (USD; Tot_Drug_Cst)2020 Drug cost: $37,590 (USD; Tot_Drug_Cst)2021 Drug cost: $176,321 (USD; Tot_Drug_Cst)2022 Drug cost: $780,431 (USD; Tot_Drug_Cst)2023 Drug cost: $1,128,979 (USD; Tot_Drug_Cst)2024 Drug cost: $1,233,806 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R16$649
20171238$5,756
20181975$856
201948113$7,444
202078248$37,590
20213791,080$176,321
20226414,091$780,431
20236984,895$1,128,979
20247125,246$1,233,806

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more114150$117
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes169244$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more404542$93
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function269269$49
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report379469$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban37626,591$491,052
XareltoRivaroxaban14011,040$197,640
EntrestoSacubitril/Valsartan1168,114$172,383
Repatha SureclickEvolocumab2238,884$165,911
JardianceEmpagliflozin362,580$47,917

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$12,580Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian M. Renard?

Tedicare shows public-source Medicare data for Brian M. Renard (NPI 1609160415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian M. Renard have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian M. Renard?

Brian M. Renard is linked to BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (billing NPI 1578072906) in the available physician profile data.

Does Brian M. Renard have Open Payments data?

Brian M. Renard has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.